Inpatient Discharge Summary
_______________________________

[B-NAME]Marilyn Foster[O], MRN# [B-ID]347895604[O], is a [B-AGE]52 y.o.[O] female, admitted to the Cardiology service for chest pain and shortness of breath. 

Admission Date: [B-DATE]2/12/2023[O] 
Discharge Date: [B-DATE]2/18/2023[O]
Attending Provider: Dr. [B-NAME]Emily Stanton[O]

Hospital Problems Noted - Resolved:

1. Acute myocardial infarction [B-DATE]2/12/2023[O] - Present Yes
2. Hypertension [B-DATE]2/12/2023[O] - Present Yes 
3. Dyslipidemia [B-DATE]2/12/2023[O] - Present Yes 

Resolved Problems:

1. Angina Pectoris [B-DATE]2/12/2023[O] - [B-DATE]2/18/2023[O] Yes

Other Problems: None

Recommendations for Follow-Up:
Medical follow-up in [B-ORGANIZATION]Riverside Medical Clinic[O] [B-PHONE]521-897-3210[O]

Next Steps: Follow-Up Instructions:
Patient is advised to maintain a low-salt, low-cholesterol diet, perform moderate physical activity as tolerated, and monitor blood pressure daily. Attend cardiac rehabilitation starting [B-DATE]2/25/2023[O].

Significant Diagnostic Studies:

1. Echocardiogram [B-DATE]2/13/2023[O]: Demonstrated reduced ejection fraction of 40%, indicating some level of systolic dysfunction.
2. Cardiac Catheterization [B-DATE]2/14/2023[O]: Revealed 70% stenosis in the left anterior descending artery, which was subsequently stented.

Discharge Medication List:

1. Aspirin 81 mg tablet: Daily
2. Lisinopril 10 mg tablet: Daily
3. Atorvastatin 20 mg tablet: Nightly
4. Metoprolol 50 mg extended-release tablet: Twice daily

All prescriptions have 0 refills; patient advised to follow up with primary care provider [B-NAME]Linda Grey[O], MD, for continuation.

Discharge Condition: Stable

Disposition: Home with home health care services from [B-ORGANIZATION]Healing Hands Home Health[O].

LACE - Readmission Risk Score:
15 Total Score (Last filed: [B-DATE]2/18/2023[O] 1542)
4 Length of Stay
5 Acute Admission
6 Charleson Comorbidity Score

Criteria that do not apply:
ED Visits in last 6 months

Patient is at high risk for unplanned Readmission or Death within 30 days of discharge. Recommended close monitoring and early follow-up appointment.
_______________________________

Signed: [B-NAME]Emily Stanton[O], MD, [B-DATE]2/18/2023[O], 5:00 PM
Supervising Physician: I was readily available for consultation upon request. I agree with the note and plan which I have reviewed and edited where appropriate. [B-NAME]Alan Briggs[O], MD Senior Attending Physician

This document contains a synthetic clinical narrative generated to illustrate the application of PHI de-identification in a discharge summary report. All personal identifiers, dates, and contact information are fictional and formatted according to HIPAA guidelines for educational and illustrative purposes.
